Overall Technical outlook

Price Summary

On 2026-10-19, Regeneron Pharmaceuticals, Inc.'s stock opened at 792.59, spiked to 800.0, declined to 780.83, and closed -1.33% lower at 782.04, with 489600 shares traded.
In the 52-week period, the stock's peak price is 852.03, and the lowest price recorded is 0.0.

Technicals

Support and Resistance: With the current price at 782.04, support is found at 774.11 and resistance at 799.08. These levels indicate where buyers might step in at 774.11, while sellers could limit gains at 799.08, defining a trading boundary for Regeneron Pharmaceuticals, Inc..
REGN supportResistance 271062
Support/Resistance for REGN
Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
REGN aroon 271062
Aroon chart for Regeneron Pharmaceuticals, Inc.
Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
REGN bbands 271062
Bolinger Bands chart for Regeneron Pharmaceuticals, Inc.
Parabolic SAR: The PSAR continues to indicate a bullish outlook, setting a crucial support level. This strong support could bolster the ongoing upward trend, suggesting that the market may remain in a positive trajectory. Investors may view this as a sign of sustained bullish momentum.
REGN psar 271062
Parabolic Stop and Reverse chart for Regeneron Pharmaceuticals, Inc.
Stochastic: The STOCHASTIC is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for REGN, with no strong trend emerging.
REGN stoch 271062
Stochastic chart for Regeneron Pharmaceuticals, Inc.
Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for REGN. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
REGN trippleSMA 271062
Tripple SMA chart for Regeneron Pharmaceuticals, Inc.

When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.